Covid vaccination guidance – April 2021
New guidance issued over the last month largely relates to changes in advice around the use of the AstraZeneca vaccine, and licensing of the Moderna vaccine.
AstraZeneca
Lots of guidance relating to the AstraZeneca vaccine has been issued or updated in April, following concerns about the risk of blood clots and subsequent MHRA advice on this risk.
- Patient information leaflet, updated 15 April 2021.
- Healthcare professional information leaflet, updated 15 April 2021.
- Conditions of Authorisation, updated 15 April 2021.
- Summary of the Public Assessment Report, updated 15 April 2021.
- Information for healthcare professionals on blood clotting following Covid-19 vaccination, updated 9 April 2021.
- MHRA confirms that people should continue to receive the Covid-19 vaccine AstraZeneca, updated 7 April 2021.
- MHRA issues new advice, concluding a possible link between Covid-19 Vaccine AstraZeneca and extremely rare, unlikely to occur blood clots, published 7 April.
Moderna
The Moderna vaccine has now been approved for use and is currently being provided at three sites in London. If and when it is made widely available to GP run sites, we will provide further updates.
- Patient information leaflet, updated 19 April 2021.
- Patient Group Direction, updated 19 April 2021.
- Regulatory approval documents, updated 19 April 2021.
- National protocol, updated 8 April 2021.
- Letter from the JCVI on use of the Moderna vaccine in the Covid-19 immunisation programme, published 7 April 2021.
Covid-19 antiviral pilots (16 Dec 2021)
The government announced this month that thousands of the UK’s most vulnerable people will be among the first in the world to access a new antiviral treatment for Covid-19, Molnupiravir....Registering overseas vaccinations at vaccination sites (16 Dec 2021)
On 9 December the Government updated guidance advising patients who wish to add an overseas Covid-19 vaccination to their NHS record to do so by booking a specific type of...Guidance updates December 2021 (16 Dec 2021)
The most important pieces of guidance released for general practice since our last newsletter are: Regulatory approval of Pfizer/BioNTech vaccine for COVID-19 and Regulatory approval of Spikevax...PCSE updates on contact details and pooled lists (16 Dec 2021)
Correct contact details Practices can improve communications with PCSE by ensuring that they have the most up to date practice contact details, including: The main practice contact All user...MP engagement and government consultations (16 Dec 2021)
During late November and December 2021 representatives from Londonwide LMCs have continued to meet with MPs, councillors and the police to raise issues affecting practices. We have also submitted evidence...Tips of the month December 2021 (16 Dec 2021)
We provide weekly tips based on common queries which come through to us from London GPs and practice teams. These are shared via social media and collated for...Dr Michelle Drage’s Christmas and New Year message (16 Dec 2021)
Thank you for simply still being here after the year you and all London general practices have had. With relentless pressure coming from clinically necessary activity, and the equally relentless...Annual General Meeting for Londonwide LMCs and Londonwide Enterprise Ltd (16 Dec 2021)
The Annual General Meeting for Londonwide LMCs and Londonwide Enterprise Ltd will be held on Thursday 20 January 2022 between 2:00pm and 3.15pm. The AGM is a chance to meet...Londonwide LMCs' December 2021 Newsletter (16 Dec 2021)
Guidance
We provide expert guidance for practices in our guidance section, as well as an archive of other materials you may find useful.
GP Support
Contact our GP Support team if you need help or advice.
The team provide professional and pastoral support to GPs and practice teams on a broad range of issues.
follow us on...
